… as slow speed, small steps, and high variability from step to step are common in people with Parkinson's disease, and these changes … which is also related to poorer health outcomes. To prevent this cascade of events, Dr. Gammon Earhart is …

… Many people with Parkinson's disease (PD) experience dystonia -- prolonged muscle contractions that can cause … movements and postures -- as a symptom of disease or a complication of treatment. Dystonia can be a disease by … worldwide. Her research focuses on task-specific dystonia where involuntary muscle contractions affect one body part …

… funded over $1 million in high-risk, high-reward approaches to Parkinson’s therapeutic development through its … annually to support research with little to no existing preliminary data, but potential to crack open entirely new … fast,” said Katie Hood, CEO of MJFF. “This reflects our commitment to keep fresh ideas flowing into the Parkinson’s …

… One of this protein’s normal functions involves binding to fatty acids and lipids, and numerous studies show that … in the brain, cerebrospinal fluid and plasma of people with PD. These observations suggest that interactions … and pathogenically important. We have shown that the presence of excess or mutant alpha-synuclein induces an …

… Michael J. Fox Foundation (MJFF) announces 69 grants that total $60.6 million awarded in April and May 2025.  These … a wide range of data from participants, including clinic visit and patient-reported information, brain imaging scans … targeting mitochondria.  More PPMI-driven research is coming, including from MJFF’s new PPMI Biofluid Biomarkers …

… for Parkinson's with GBA teamed up on this funding program to leverage resources and streamline review 16 selected … beta acid (GBA). Mutations in the GBA gene are the most common genetic risk factors for Parkinson's, affecting about … of Team Fox members around the world. For more information, visit www.michaeljfox.org. About The Silverstein Foundation …